Literature DB >> 7687780

Impact of benign prostatic hyperplasia on general well-being of men.

K K Tsang1, W M Garraway.   

Abstract

Little is known about the impact of benign prostatic hyperplasia (BPH) on the general well-being of men with this condition. All men aged 40-79 years registered with a group general practice were enumerated. BPH was defined as enlargement of the prostate gland of equivalent weight > 20 g in the presence of symptoms of urinary dysfunction and/or a urinary peak flow rate < 15 ml/s, without evidence of malignancy. Four hundred and ten men (20% of those who participated) satisfied these criteria. The proportion of men with a negative feeling of well-being was higher in men with BPH than in men who did not have BPH. The difference was consistent for all aspects of well-being (anxiety, depression, self-control, vitality, being worried or being bothered by illness). Men with BPH had a higher level of bothersomeness attributed to urinary symptoms, and more interference in selected daily living activities caused by urinary dysfunction. These were related to worry or concern over urinary function and prostate cancer, together with a higher level of embarrassment caused by urinary dysfunction, compared with men who did not have BPH. Patients' feelings of well-being should be taken into account in the clinical management of BPH.

Entities:  

Mesh:

Year:  1993        PMID: 7687780     DOI: 10.1002/pros.2990230102

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Authors:  B Mozes; Y Maor; A Shmueli
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

Review 3.  Dietary patterns, supplement use, and the risk of benign prostatic hyperplasia.

Authors:  Kenneth S Poon; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

4.  Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia.

Authors:  R Arocho; C A McMillan; P Sutton-Wallace
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

5.  Perceptions of urinary symptoms and health-care-seeking behaviour amongst men aged 40-79 years.

Authors:  S Cunningham-Burley; H Allbutt; W M Garraway; A J Lee; E B Russell
Journal:  Br J Gen Pract       Date:  1996-06       Impact factor: 5.386

6.  Quality of life bibliography and indexes: 1993 update.

Authors:  R A Berzon; G P Simeon; R L Simpson; M A Donnelly; H H Tilson
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

7.  Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery.

Authors:  A S Salinas-Sánchez; I Hernández-Millán; J G Lorenzo-Romero; M Segura-Martin; C Fernández-Olano; J A Virseda-Rodriguez
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

8.  Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.

Authors:  R S Kirby; G Chisholm; C Chapple; C Hudd; M Swallow; D Shore
Journal:  J R Soc Med       Date:  1995-05       Impact factor: 5.344

9.  Development of a quality of life scale specific for patients with benign prostatic hyperplasia.

Authors:  Kamil Cam; Talha Muezzinoglu; Omer Aydemir; Recep Buyukalpelli; Gokhan Toktas; Hakan Gemalmaz
Journal:  Int Urol Nephrol       Date:  2013-02-19       Impact factor: 2.370

10.  The impact of lower urinary tract symptoms on general health status and on the use of prostatectomy.

Authors:  D J Hunter; C M McKee; N A Black; C F Sanderson
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.